ResMed (ASX:RMD) Chief Financial Officer Brett Sandercock sold 3,644 shares on the New York Stock Exchange for about $891,286 in total, according to a Friday filing with the Australian bourse.
Following the sale of shares, Sandercock owns about 146.6 million shares in the company, per the filing.